Chapter 15
Cancer
Copyright © 2020 by Elsevier, Inc. All rights reserved.
Cancer (1 of 5)
Group of diseases characterized by uncontrolled
and unregulated growth of cells
Occurs in people of all ages
➢ Most cases are diagnosed in those over age 55
Copyright © 2020 by Elsevier, Inc. All rights reserved. 2
Cancer (2 of 5)
Both the incidence and mortality rate of cancer has
been declining
➢ Incidences of lung, colorectal, breast, and oral cancer
have decreased
➢ Other cancers have increased
Copyright © 2020 by Elsevier, Inc. All rights reserved. 3
Cancer (3 of 5)
Higher in men than women
Second most common cause of death in United
States after heart disease
➢ Leading cause of death in people 40 to 79 years of
age
Copyright © 2020 by Elsevier, Inc. All rights reserved. 4
Cancer (4 of 5)
Greater than 14.5 million Americans are alive today
who have a history of cancer
➢ Disease free
➢ In remission
➢ Under treatment
Copyright © 2020 by Elsevier, Inc. All rights reserved. 5
Cancer (5 of 5)
Statistics cannot describe the combined
physiologic, psychologic, and social impact of
cancer on individual patients, their caregivers,
and families.
(©Comstock/Thinkstock)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 6
Biology of Cancer
Two major dysfunctions in the process of cancer
development:
1. Defective cell proliferation (growth)
2. Defective cell differentiation
Copyright © 2020 by Elsevier, Inc. All rights reserved. 7
Defect in Cellular Differentiation
(1 of 3)
Two types of genes that can be affected by mutation
are
➢ Protooncogenes
• Regulate normal cellular processes such as promoting
growth
➢ Tumor suppressor genes
• Suppress growth
Copyright © 2020 by Elsevier, Inc. All rights reserved. 8
Defect in Cellular Differentiation
(2 of 3)
Protooncogenes
➢ Genetic locks that keep cells functioning normally
➢ Mutations that alter their expression can activate
them to function as oncogenes
Copyright © 2020 by Elsevier, Inc. All rights reserved. 9
Defect in Cellular Differentiation
(3 of 3)
Tumor suppressor genes
➢ Function to regulate cell growth
• Prevent cells from going through the cell cycle
➢ Mutations make them inactive
• Result in loss of suppression of tumor growth
Copyright © 2020 by Elsevier, Inc. All rights reserved. 10
Development of Cancer (1 of 11)
Initiation
➢ First stage
➢ Mutation of cell’s genetic structure
• Any change in usual DNA sequence
Copyright © 2020 by Elsevier, Inc. All rights reserved. 11
Gene Mutations
Inherited
➢ About 5% to 10% of all cancers or predisposition to
cancers are inherited
➢ Lead to a very high risk for cancer
Acquired
➢ Most cancers are acquired
Copyright © 2020 by Elsevier, Inc. All rights reserved. 12
Carcinogens
Cancer-causing agents capable of producing cell
alterations
➢ Many are detoxified by protective enzymes and are
harmlessly excreted
➢ Failure of protective mechanisms allows them to enter
cell’s nucleus and alter DNA
Copyright © 2020 by Elsevier, Inc. All rights reserved. 13
Development of Cancer (2 of 11)
Carcinogens may be
➢ Chemical
➢ Radiation
➢ Viral
Copyright © 2020 by Elsevier, Inc. All rights reserved. 14
Development of Cancer (3 of 11)
Chemical carcinogens
➢ Many chemicals have been identified as carcinogens
over the years
• Benzene
• Arsenic
• Formaldehyde
Copyright © 2020 by Elsevier, Inc. All rights reserved. 15
Development of Cancer (4 of 11)
Radiation
➢ Radiation can cause cancer in almost any human
tissue
➢ Damage occurs to DNA
➢ Ultraviolet radiation is associated with melanoma and
squamous and basal cell carcinoma
• Sunlight is main source of UV exposure
Copyright © 2020 by Elsevier, Inc. All rights reserved. 16
Development of Cancer (5 of 11)
Viral carcinogens
➢ Epstein-Barr virus (EBV)
• Burkitt’s lymphoma
➢ Human immunodeficiency virus (HIV)
• Kaposi sarcoma
➢ Hepatitis B virus
• Hepatocellular carcinoma
➢ Human papillomavirus (HPV)
• Squamous cell carcinomas
Copyright © 2020 by Elsevier, Inc. All rights reserved. 17
Development of Cancer (6 of 11)
Promotion
➢ Characterized by reversible proliferation of altered
cells
➢ Activities of promotion are reversible
• Obesity
• Smoking
• Alcohol use
• Dietary fat
Copyright © 2020 by Elsevier, Inc. All rights reserved. 18
Development of Cancer (7 of 11)
Latent period
➢ May range from 1 to 40 years
➢ Length of latent period associated with mitotic rate of
tissue of origin and environmental factors
➢ For disease to be clinically evident, tumor must reach
a critical mass that can be detected
Copyright © 2020 by Elsevier, Inc. All rights reserved. 19
Development of Cancer (8 of 11)
Progression
➢ Characterized by
• Increased growth rate of tumor
• Invasiveness
• Metastasis
Copyright © 2020 by Elsevier, Inc. All rights reserved. 20
Main Sites of Metastasis
Fig. 15-3
Copyright © 2020 by Elsevier, Inc. All rights reserved. 21
Development of Cancer (9 of 11)
Progression
➢ Metastasis process begins with rapid growth of
primary tumor
• Develops its own blood supply
Tumor angiogenesis
• Tumor cells can detach and invade surrounding tissues
Copyright © 2020 by Elsevier, Inc. All rights reserved. 22
Development of Cancer (10 of 11)
Progression
➢ Metastasis process
• Detached cells can invade lymph nodes and vascular vessels
to travel to distant sites
• Most mobile tumor cells do not survive
• Surviving tumor cells must create an environment conducive
to growth and development
Copyright © 2020 by Elsevier, Inc. All rights reserved. 23
Development of Cancer (11 of 11)
Progression
➢ Sentinel lymph node
• First node confronted as tumor cells spread through the
lymphatic system
• Biopsy can help determine extent of cancer
➢ Skip metastasis
• When tumor cell travel to distant nodes
Copyright © 2020 by Elsevier, Inc. All rights reserved. 24
Role of Immune System (1 of 8)
Immune response is to reject or destroy cancer cells
➢ May be inadequate as cancer cells arise from normal
human cells
Some cancer cells have changes on their surface
antigens
➢ Tumor-associated antigens (TAAs)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 25
Benign Versus Malignant
Neoplasms
Tumors can be classified as benign or malignant
Ability of malignant tumor cells to invade and
metastasize is major difference between benign
and malignant neoplasms
Copyright © 2020 by Elsevier, Inc. All rights reserved. 26
Classification of Cancer (1 of 13)
Tumors can be classified by
➢ Anatomic site
➢ Histology
• Grading severity
➢ Extent of disease
• Staging
Copyright © 2020 by Elsevier, Inc. All rights reserved. 27
Classification of Cancer (2 of 13)
Classification systems provide a standardized way
to
➢ Communicate with health care team
➢ Prepare and evaluate treatment plan
➢ Determine prognosis
➢ Compare groups statistically
Copyright © 2020 by Elsevier, Inc. All rights reserved. 28
Classification of Cancer (3 of 13)
Anatomic site classification
➢ Identified by tissue of origin
➢ Carcinomas originate from
• Embryonal ectoderm (skin, glands)
• Endoderm (mucous membrane of respiratory tract, GI
and GU tracts)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 29
Classification of Cancer (4 of 13)
Anatomic site classification
➢ Sarcomas originate from
• Embryonal mesoderm (connective tissue, muscle,
bone, and fat)
➢ Lymphomas and leukemias originate from
• Hematopoietic system
Copyright © 2020 by Elsevier, Inc. All rights reserved. 30
Classification of Cancer (5 of 13)
Histologic classification
➢ Appearance of cells and degree of differentiation are
evaluated to determine how closely cells resemble
tissue of origin
➢ Poorly differentiated tumors have a poorer prognosis
than those closer in appearance to normal cells
Copyright © 2020 by Elsevier, Inc. All rights reserved. 31
Classification of Cancer (6 of 13)
Four grades of abnormal cells
➢ Grade I
• Cells differ slightly from normal cells and are well
differentiated
➢ Grade II
• Cells are more abnormal and moderately differentiated
Copyright © 2020 by Elsevier, Inc. All rights reserved. 32
Classification of Cancer (7 of 13)
Four grades
➢ Grade III
• Cells are very abnormal and poorly differentiated
➢ Grade IV
• Cells are immature and primitive and undifferentiated
• Cell of origin is difficult to determine
Copyright © 2020 by Elsevier, Inc. All rights reserved. 33
Classification of Cancer (8 of 13)
Clinical staging classifications
➢ 0: Cancer in situ
➢ I: Tumor limited to tissue of origin; localized tumor
growth
➢ II: Limited local spread
➢ III: Extensive local and regional spread
➢ IV: Metastasis
Copyright © 2020 by Elsevier, Inc. All rights reserved. 34
Classification of Cancer (9 of 13)
TNM classification system
➢ Anatomic extent of disease is based on three
parameters:
• Tumor size and invasiveness (T)
• Spread to lymph nodes (N)
• Metastasis (M)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 35
Classification of Cancer (10 of 13)
Staging
➢ Performed initially and at several evaluation points
• Clinical staging
• Surgical staging
Copyright © 2020 by Elsevier, Inc. All rights reserved. 36
Classification of Cancer (11 of 13)
Clinical staging
➢ Done at completion of diagnostic workup to guide
effective treatment selection
• Bone and liver scans, ultrasonography, CT, MRI, PET
scans
Copyright © 2020 by Elsevier, Inc. All rights reserved. 37
Classification of Cancer (12 of 13)
Surgical staging
➢ Determined by surgical excision, exploration, and/or
lymph node sampling
➢ Exploratory surgical staging is being used less
frequently
Copyright © 2020 by Elsevier, Inc. All rights reserved. 38
Classification of Cancer (13 of 13)
Stage classification is not changed once
established
Retreatment staging is done if additional
treatment is needed or if treatment fails
➢ (rTNM)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 39
Diagnoses of Cancer (1 of 8)
Patient may experience fear and anxiety
➢ Actively listen to patient’s concerns
➢ Manage your own discomfort
➢ Give clear explanations; repeat if necessary
➢ Give written information for reinforcement
➢ Refer to oncology team when possible
Copyright © 2020 by Elsevier, Inc. All rights reserved. 40
Diagnoses of Cancer (2 of 8)
➢ Manage your own discomfort
• Avoid
Communication patterns that may hinder exploration of
feelings
Use of overly technical language
• Encourage patients to share the meaning of their
experience
• Listening is an important skill at this time
Copyright © 2020 by Elsevier, Inc. All rights reserved. 41
“Caring” Questions
What can you do if you are uncomfortable
discussing patient’s fears and concerns about
cancer?
Do you believe that it’s possible to “fix” patient’s
fears by avoiding them?
Copyright © 2020 by Elsevier, Inc. All rights reserved. 42
Diagnoses of Cancer (3 of 8)
Diagnostic plan includes
➢ Health history
• History of present illness
➢ Identification of risk factors
➢ Physical examination
➢ Specific diagnostic studies
Copyright © 2020 by Elsevier, Inc. All rights reserved. 43
Diagnoses of Cancer (4 of 8)
Indicated diagnostic studies depend on site of
cancer
➢ Cytology studies
➢ Chest x-ray
➢ CBC, chemistry profile
➢ Liver function studies
➢ Endoscopic examinations
Copyright © 2020 by Elsevier, Inc. All rights reserved. 44
Diagnoses of Cancer (5 of 8)
Indicated diagnostic studies depend on site of
cancer
➢ Radiographic studies
➢ Radioisotope scans
➢ PET scan
➢ Tumor markers
➢ Genetic markers
Copyright © 2020 by Elsevier, Inc. All rights reserved. 45
Diagnoses of Cancer (6 of 8)
Indicated diagnostic studies depend on site of
cancer
➢ Molecular receptor status
➢ Bone marrow examination
➢ Biopsy
Copyright © 2020 by Elsevier, Inc. All rights reserved. 46
Diagnoses of Cancer (7 of 8)
Biopsy involves histologic examination by a
pathologist of a piece of tissue
➢ Tissue may be obtained by
• Needle or aspiration
• Incisional procedure
• Excisional procedure
Copyright © 2020 by Elsevier, Inc. All rights reserved. 47
Diagnosis of Cancer (8 of 8)
Pathologic evaluation of a tissue sample is only
definitive means to diagnose cancer
➢ Benign or malignant
➢ Histology
➢ Histologic grade
Copyright © 2020 by Elsevier, Inc. All rights reserved. 48
Prevention is Key
The war on cancer will not be won with drugs or
radiation therapy
A stronger emphasis on prevention is needed
Nurses have an essential role
Copyright © 2020 by Elsevier, Inc. All rights reserved. 49
Education Is Essential
Goals of public education
➢ Motivate people to recognize and modify behaviors
that may negatively affect health
➢ Encourage awareness of and participation in health-
promoting behaviors
Copyright © 2020 by Elsevier, Inc. All rights reserved. 50
Prevention and Detection of
Cancer (1 of 3)
Lifestyle habits to reduce risks
➢ Practice recommended cancer screenings
➢ Practice self-examination
➢ Know “7 Warning Signs of Cancer”
➢ Seek medical care if cancer is suspected
Copyright © 2020 by Elsevier, Inc. All rights reserved. 51
Prevention and Detection of
Cancer (2 of 3)
Lifestyle habits to reduce risks
➢ Avoid or reduce exposure to known or suspected
carcinogens
• Cigarette smoke, excessive sun exposure
➢ Eat a balanced diet
➢ Limit alcohol use
➢ Exercise regularly
Copyright © 2020 by Elsevier, Inc. All rights reserved. 52
Prevention and Detection of
Cancer (3 of 3)
Lifestyle habits to reduce risks
➢ Maintain a healthy weight
➢ Get adequate rest
➢ Eliminate, reduce, or cope with stress
➢ Have a regular health examination
• Be familiar with your family history
• Know your risk factors
Copyright © 2020 by Elsevier, Inc. All rights reserved. 53
Interprofessional Care and
Complications
Copyright © 2020 by Elsevier, Inc. All rights reserved. 54
Cancer Treatment (1 of 3)
Goals
➢ Cure
➢ Control
➢ Palliation
Copyright © 2020 by Elsevier, Inc. All rights reserved. 55
Cancer Treatment (2 of 3)
Curative therapy
➢ Surgery alone or periods of adjunctive systemic
therapy
➢ Timeframe to “cure” may differ according to the tumor
and its characteristics
Control treatment
➢ Initial course and maintenance therapy
Copyright © 2020 by Elsevier, Inc. All rights reserved. 56
Cancer Treatment (3 of 3)
Palliation goal
➢ Relief or control of symptoms
➢ Maintain quality of life
Palliative care and treatment are not mutually
exclusive and can take concurrently
Copyright © 2020 by Elsevier, Inc. All rights reserved. 57
Personalized Cancer Medicine
(1 of 4)
Genetic information is used to customize decisions
about
➢ Prevention
➢ Diagnosis
➢ Treatment
Copyright © 2020 by Elsevier, Inc. All rights reserved. 58
Personalized Cancer Medicine
(2 of 4)
Targeted therapy
➢ Aims at a cancer’s specific genes or proteins that
contribute to cancer growth and survival
➢ Biopsy can help determine whether a tumor has the
specific target
Copyright © 2020 by Elsevier, Inc. All rights reserved. 59
Cancer Treatment
Surgical Therapy (1 of 4)
Surgery
➢ Oldest form of cancer treatment
➢ Meets a variety of goals
➢ Trend is toward less radical surgeries
Copyright © 2020 by Elsevier, Inc. All rights reserved. 60
Cancer Treatment
Surgical Therapy (2 of 4)
Prevention
➢ Surgery used to eliminate or reduce risk of cancer in
at-risk patients
• Prophylactic removal of nonvital organs has been
successful in reducing the incidence of some cancers
• Usual sites of regional spread may be removed
Copyright © 2020 by Elsevier, Inc. All rights reserved. 61
Cancer Treatment
Surgical Therapy (3 of 4)
Cure and control
➢ Remove only as much tissue as necessary and spare
normal tissue
➢ Debulking procedure may be used if tumor cannot be
completely removed
• Followed by chemotherapy or radiation therapy
Copyright © 2020 by Elsevier, Inc. All rights reserved. 62
Cancer Treatment
Surgical Therapy (4 of 4)
Supportive and palliative care
➢ Cure or control not possible
➢ Supportive care includes
• Insertion of gastric feeding tube
• Placement of central venous access device
• Prophylactic surgical fixation of bones at risk for
pathologic fracture
Copyright © 2020 by Elsevier, Inc. All rights reserved. 63
Chemotherapy (1 of 2)
Antineoplastic therapy
➢ Use of chemicals given as a systemic therapy for
cancer
➢ Mainstay for most solid tumors and hematologic
cancers
➢ Can offer cure, control, or palliative care
Copyright © 2020 by Elsevier, Inc. All rights reserved. 64
Goals of Chemotherapy
Fig. 15-10
Copyright © 2020 by Elsevier, Inc. All rights reserved. 65
Chemotherapy
Classification of Drugs
Classified by
➢ Molecular structure
➢ Mechanism of action
Two major categories
➢ Cell cycle phase nonspecific
➢ Cell cycle phase specific
Typically given in combination
Copyright © 2020 by Elsevier, Inc. All rights reserved. 66
Preparation and Handling of
Chemotherapy Agents
May pose an occupational hazard
Drugs may be absorbed through
➢ Skin
➢ Inhalation during preparation, transportation, and
administration
Only properly trained personnel should handle
cancer drugs
Copyright © 2020 by Elsevier, Inc. All rights reserved. 67
Chemotherapy
Methods of Administration (1 of 2)
Oral
➢ More available options today
➢ Storage and side effects
IM
IV (most common)
➢ Central venous access device (CVAD)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 68
Chemotherapy
Methods of Administration (2 of 2)
CVAD administration
➢ Placement in large blood vessels
➢ Frequent, continuous, or intermittent administration
➢ Can be used to administer other fluids (blood,
electrolytes, etc.)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 69
Chemotherapy
Regional Administration (1 of 3)
Delivery of drug directly into
tumor site
Higher concentrations of drug can be delivered
with less systemic toxicity
Copyright © 2020 by Elsevier, Inc. All rights reserved. 70
Chemotherapy
Regional Administration (2 of 3)
Types of regional delivery methods
➢ Intraarterial
• Delivers drug through arteries supplying tumor
➢ Intraperitoneal
• Delivers drug to peritoneal cavity for treatment of peritoneal
metastases
Copyright © 2020 by Elsevier, Inc. All rights reserved. 71
Chemotherapy
Regional Administration (3 of 3)
Types of regional delivery methods
Intrathecal or intraventricular
• Involves lumbar puncture and injection of
chemotherapy into subarachnoid space
➢ Intravesical bladder
• Agent added to bladder by urinary catheter and
retained for 1 to 3 hours
Copyright © 2020 by Elsevier, Inc. All rights reserved. 72
Chemotherapy
Effects on Normal Tissue (1 of 2)
Chemotherapy agents cannot distinguish
between normal and
cancer cells
Side effects are result of destruction of normal
cells
Copyright © 2020 by Elsevier, Inc. All rights reserved. 73
Chemotherapy
Effects on Normal Tissue (2 of 2)
General and drug-specific adverse effects are
classified
➢ Acute
➢ Delayed
➢ Chronic
Copyright © 2020 by Elsevier, Inc. All rights reserved. 74
Chemotherapy
Treatment Plan
Drugs given in combination
➢ Dosages are carefully calculated according to body
surface area
➢ Regimens involve drugs with different mechanisms of
action and varying toxicity profiles
Copyright © 2020 by Elsevier, Inc. All rights reserved. 75
Nursing Management
Chemotherapy
Mutation of cancer cells can result in resistance to
chemotherapy
➢ Multiple drugs that work at different places in cell
cycle can more effectively kill cancer cells
Copyright © 2020 by Elsevier, Inc. All rights reserved. 76
Cancer Treatment
Radiation Therapy (1 of 11)
One of the oldest nonsurgical methods of cancer
treatment
50% of all cancer patients will receive radiation
therapy at some point in their treatment
Copyright © 2020 by Elsevier, Inc. All rights reserved. 77
Cancer Treatment
Radiation Therapy (2 of 11)
Radiation is emission of energy from a source
and travels through space or some material
Different types of ionizing radiation are used to
treat cancer
Technologic advances
Copyright © 2020 by Elsevier, Inc. All rights reserved. 78
Cancer Treatment
Radiation Therapy (3 of 11)
Low-energy beams
➢ Expend energy quickly
➢ Penetrate a short distance
➢ Useful for skin lesions
High-energy beams
➢ Greater depth of penetration
➢ Suitable for optimal dosing of internal targets while
sparing skin
Copyright © 2020 by Elsevier, Inc. All rights reserved. 79
Cancer Treatment
Radiation Therapy (4 of 11)
Historically, the radiation dose was expressed in
units called rads (radiation absorbed doses)
Current nomenclature is gray (Gy) or centigray
(cGy)
A centigray is equivalent to 1 rad and 100
centigray equals 1 gray
Copyright © 2020 by Elsevier, Inc. All rights reserved. 80
Cancer Treatment
Radiation Therapy (5 of 11)
Total doses divided into fractions
Typically delivered once a day for 5 days a week for
2 to 8 weeks
➢ Standard fractionation
Certain tumors are more susceptible to the effects of
radiation than others
Copyright © 2020 by Elsevier, Inc. All rights reserved. 81
Cancer Treatment
Radiation Therapy (6 of 11)
Simulation
➢ A process by which radiation treatment fields are
defined, filmed, and marked out on skin
➢ Radiation oncologist specifies dose and volume of
area to be treated
Copyright © 2020 by Elsevier, Inc. All rights reserved. 82
Cancer Treatment
Radiation Therapy (7 of 11)
Simulation
➢ Target tumor defined using
• Variety of imaging techniques
• Physical examination and surgical reports
➢ Marks placed on skin to outline treatment field
Copyright © 2020 by Elsevier, Inc. All rights reserved. 83
Cancer Treatment
Radiation Therapy (8 of 11)
Radiation is used to treat a carefully defined area of
the body
➢ Not a primary treatment for systemic disease
➢ May be used by itself or with chemotherapy or
surgery
• To treat primary tumors
• For palliation of metastatic lesions
Copyright © 2020 by Elsevier, Inc. All rights reserved. 84
Cancer Treatment
Radiation Therapy (9 of 11)
External radiation (teletherapy)
➢ Most common radiation treatment
➢ Patient exposed to radiation from a megavolt machine
• Gamma knife technology—Cobalt
• Cyclotron—Neutrons or protons
• Linear accelerator—Ionizing radiation
Copyright © 2020 by Elsevier, Inc. All rights reserved. 85
Cancer Treatment
Radiation Therapy (10 of 11)
Internal radiation (brachytherapy)
➢ Implantation or insertion of radioactive materials into
or close to tumor
➢ Minimal exposure to healthy tissue
➢ Commonly used in combination with external
radiation
Copyright © 2020 by Elsevier, Inc. All rights reserved. 86
Cancer Treatment
Radiation Therapy (11 of 11)
Internal radiation
➢ Patient is emitting radioactivity
➢ Limit amount of time near patients being treated
• Organize care
• Use shielding
• Wear film badge to monitor exposure
Copyright © 2020 by Elsevier, Inc. All rights reserved. 87
Nursing Management
Nursing Implications (1 of 11)
Common side effects
➢ Bone marrow suppression
➢ Fatigue
➢ GI problems
➢ Integumentary and mucosal reactions
➢ Pulmonary effects
➢ Reproductive effects
Copyright © 2020 by Elsevier, Inc. All rights reserved. 88
Nursing Management
Nursing Implications (2 of 11)
Bone marrow suppression
➢ Myelosuppression: most common side effect of
chemotherapy
➢ Treatment-induced reductions in RBCs and WBCs
can result in
• Infection
• Hemorrhage
• Overwhelming fatigue
Copyright © 2020 by Elsevier, Inc. All rights reserved. 89
Nursing Management
Nursing Implications (3 of 11)
Fatigue
➢ Encourage conservation strategies
• Rest before activity
• Get assistance with activity
• Remain active during periods of time patients feel
better
➢ Maintain nutritional and hydration status
➢ Assess for reversible causes of fatigue
Copyright © 2020 by Elsevier, Inc. All rights reserved. 90
Nursing Management
Nursing Implications (4 of 11)
Gastrointestinal (GI) effects
➢ Prophylactic administration of antiemetics
➢ Assess for signs and symptoms of
• Alkalosis, dehydration, and I and O
➢ Nonirritating, low-fiber,
high-calorie, high-protein diet
Copyright © 2020 by Elsevier, Inc. All rights reserved. 91
Nursing Management
Nursing Implications (5 of 11)
GI effects
➢ Antidiarrheal, antimotility, and antispasmodic
medications
➢ Anorexia
• Monitor carefully to avoid weight loss
Weigh twice weekly
• Recommend small, frequent, high-protein,
high-calorie meals
• Involve dietitian before treatment begins
Copyright © 2020 by Elsevier, Inc. All rights reserved. 92
Nursing Management
Nursing Implications (6 of 11)
Skin reactions
➢ Occur in radiation treatment field
➢ Acute or chronic
• Develop 1 to 24 hours after treatment
• Generally progressive as treatment dose accumulates
Copyright © 2020 by Elsevier, Inc. All rights reserved. 93
Dry Desquamation
Fig. 15-14
Copyright © 2020 by Elsevier, Inc. All rights reserved. 94
Wet Desquamation
Fig. 15-15
Copyright © 2020 by Elsevier, Inc. All rights reserved. 95
Nursing Management
Nursing Implications (7 of 11)
Skin reactions
➢ Prevent infection
➢ Facilitate wound healing
➢ Protect irritated skin temperature extremes
➢ Avoid constricting garments, harsh chemicals, and
deodorants
➢ Help patients deal with hair loss (alopecia)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 96
Nursing Management
Nursing Implications (8 of 11)
Pulmonary effects
➢ May be progressive and irreversible
➢ Cough, dyspnea, pneumonitis, pulmonary edema
➢ Treatment
• Bronchodilators
• Expectorants/cough suppressants
• Bed rest
• Oxygen
Copyright © 2020 by Elsevier, Inc. All rights reserved. 97
Nursing Management
Nursing Implications (9 of 11)
Cardiovascular effects
➢ Patients with preexisting coronary artery disease are
more vulnerable
➢ Baseline and periodic echocardiograms are often
done
Copyright © 2020 by Elsevier, Inc. All rights reserved. 98
Nursing Management
Nursing Implications (10 of 11)
Cognitive effects
➢ “Chemo” brain
➢ Often described as mental cloudiness or fog
➢ Can last for a short time or for years
➢ Can be severe
Copyright © 2020 by Elsevier, Inc. All rights reserved. 99
Nursing Management
Nursing Implications (11 of 11)
Reproductive effects
➢ Inform patient of expected sexual side effects
➢ Use appropriate shielding
➢ Encourage discussion of issues related to
reproduction and sexuality
➢ Refer to counseling if needed
Copyright © 2020 by Elsevier, Inc. All rights reserved. 100
Late Effects of Radiation and
Chemotherapy
Most at risk are patients treated with alkylating
agents and high-dose radiation
➢ May be progressive
➢ Generally permanent
Secondary cancers
➢ Leukemia, angiosarcoma, skin cancer
Copyright © 2020 by Elsevier, Inc. All rights reserved. 101
Immunotherapy
Immunotherapy uses the immune system to fight
cancer
Some types called biologic therapy
Boost or manipulate the immune system and
create an environment not conducive for cancer
cells to grow
Attack cancer cells directly
Copyright © 2020 by Elsevier, Inc. All rights reserved. 102
Targeted Therapy (1 of 2)
Interferes with cancer growth by targeting specific
cell receptors and pathways that are important in
tumor growth
➢ Does less damage to normal cells
➢ Agents that target specific oncogenes are being
developed
Copyright © 2020 by Elsevier, Inc. All rights reserved. 103
Immunotherapy and Targeted
Therapy (1 of 3)
Side effects
➢ Flulike symptoms
➢ Anorexia/weight loss
➢ Fatigue, malaise, weakness
➢ Nausea/vomiting
➢ Photosensitivity
Copyright © 2020 by Elsevier, Inc. All rights reserved. 104
Immunotherapy and Targeted
Therapy (2 of 3)
Tachycardia and orthostatic hypotension are
common
CNS system effects
Hepatotoxicity
Renal system effects
Copyright © 2020 by Elsevier, Inc. All rights reserved. 105
Immunotherapy and Targeted
Therapy (3 of 3)
Nursing Management
➢ Side effects occur more acutely and are dose limited
➢ Can influence patient decision to continue therapy
➢ May not be reported for fear treatment may be
stopped
Copyright © 2020 by Elsevier, Inc. All rights reserved. 106
Hormone Therapy
Sex hormones
➢ Can stop the growth of cancer cells
Corticosteroids
➢ Used in combination with drug regimens to help curb
side effects
Copyright © 2020 by Elsevier, Inc. All rights reserved. 107
Hematopoietic Growth Factors
Colony-stimulating factors
➢ Glycoproteins that stimulate production, maturation,
regulation, and activation of cells in hematologic
system
➢ May hasten recovery from bone marrow depression
or reestablish bone marrow function
Copyright © 2020 by Elsevier, Inc. All rights reserved. 108
Hematopoietic Stem Cell
Transplantation (HSCT) (1 of 7)
Bone marrow transplant (BMT)
Peripheral stem cell transplantation (PSCT)
Allows high doses for treatment
➢ Failing to respond to standard doses of chemotherapy
or radiation
➢ Develop resistance (refractory)
Copyright © 2020 by Elsevier, Inc. All rights reserved. 109
Hematopoietic Stem Cell
Transplantation (HSCT) (2 of 7)
Procedure with many risks, including death
Highly toxic
Overall cure rates are steadily increasing
Tumor cells are eradicated and bone marrow is
rescued by infusing healthy cells
Copyright © 2020 by Elsevier, Inc. All rights reserved. 110
Hematopoietic Stem Cell
Transplantation (HSCT) (3 of 7)
HSCT may be categorized as
➢ Allogeneic, syngeneic, and autologous
Sources of cells include
➢ Bone marrow
➢ Peripheral blood
➢ Umbilical cord blood
Copyright © 2020 by Elsevier, Inc. All rights reserved. 111
Autologous Stem Cell Transplant
Fig. 15-17
Copyright © 2020 by Elsevier, Inc. All rights reserved. 112
Hematopoietic Stem Cell
Transplantation (HSCT) (4 of 7)
Stem cells from bone marrow
➢ Procedure is performed in OR under general or spinal
anesthesia
➢ Multiple aspirations are carried out to obtain adequate
number of stem cells
• Usually from iliac crest or sometimes from sternum
Copyright © 2020 by Elsevier, Inc. All rights reserved. 113
Hematopoietic Stem Cell
Transplantation (HSCT) (5 of 7)
Stem cells from bone marrow
➢ Marrow is processed to remove bone fragments
➢ Cells are cryopreserved until infused
Copyright © 2020 by Elsevier, Inc. All rights reserved. 114
Hematopoietic Stem Cell
Transplantation (HSCT) (6 of 7)
Stem cells from peripheral blood
➢ Outpatient procedure
➢ Cell separation equipment sorts stem cells out, and
other cells are returned to donor
➢ Procedure takes 2 to 4 hours
➢ Multiple collections may be needed
Copyright © 2020 by Elsevier, Inc. All rights reserved. 115
Hematopoietic Stem Cell
Transplantation (HSCT) (7 of 7)
Stem cells from cord blood
➢ Umbilical cord blood can be HLA-typed and
cryopreserved
➢ May have insufficient numbers of stem cells to permit
transplant to adults
➢ Research is ongoing
Copyright © 2020 by Elsevier, Inc. All rights reserved. 116
Posttransplant Complications
Bacterial, viral, and fungal infections are common
➢ Prophylactic antibiotic therapy
Graft-versus-host disease
➢ T cells from donor (graft) marrow recognize recipient
(host) as foreign
➢ Attacks organs such as skin, liver, and GI tract
Copyright © 2020 by Elsevier, Inc. All rights reserved. 117
Gene Therapy
Experimental therapy
➢ Genetic material is introduced into cells to fight
disease
➢ Investigational
Copyright © 2020 by Elsevier, Inc. All rights reserved. 118
Complications of Cancer
Patients with cancer may develop complications
from
➢ Continual growth of the cancer into normal tissue
➢ Side effects of treatment
Copyright © 2020 by Elsevier, Inc. All rights reserved. 119
Complications of Cancer
Nutritional Problems (1 of 2)
Malnutrition
➢ Fat and muscle depletion
➢ Nutritional counseling
• When 5% weight loss is noted
• Patient has potential for protein and calorie malnutrition
Copyright © 2020 by Elsevier, Inc. All rights reserved. 120
Complications of Cancer
Nutritional Problems (2 of 2)
Altered taste sensation (dysgeusia)
➢ Physiologic basis of altered taste is unknown
➢ Teach patient to
• Avoid foods they dislike
• Experiment with spices and seasonings to mask
alterations
Copyright © 2020 by Elsevier, Inc. All rights reserved. 121
Cancer Cachexia
Wasting syndrome
➢ Anorexia and/or unintended loss of weight and
appetite
• Generalized tissue wasting
• Skeletal muscle atrophy
• Immune dysfunction
• Metabolic abnormalities
Copyright © 2020 by Elsevier, Inc. All rights reserved. 122
Complications of Cancer
Infection (1 of 2)
Primary cause of death
Usual sites of infection
➢ Lungs
➢ Genitourinary tract system
➢ Mouth, rectum
➢ Peritoneal cavity
➢ Blood
Copyright © 2020 by Elsevier, Inc. All rights reserved. 123
Complications of Cancer
Infection (2 of 2)
Occurs due to
➢ Ulceration
➢ Compression of vital organs by tumor
➢ Neutropenia caused by disease or treatment
Copyright © 2020 by Elsevier, Inc. All rights reserved. 124
Complications of Cancer
Oncologic Emergencies
Life-threatening
Occur as the result of disease or treatment
Emergencies can be
➢ Obstructive
➢ Metabolic
➢ Infiltrative
Copyright © 2020 by Elsevier, Inc. All rights reserved. 125
Cancer Pain (1 of 2)
Patient report should always be believed and
accepted as primary source for pain assessment
data
Drug therapy should be used to control pain
Copyright © 2020 by Elsevier, Inc. All rights reserved. 126
Cancer Pain (2 of 2)
Undertreatment of pain causes
➢ Needless suffering
➢ Decreased quality of life
➢ Increased burden on family caregivers
Inadequate pain assessment is single greatest
barrier to effective cancer pain management
Copyright © 2020 by Elsevier, Inc. All rights reserved. 127
Managing Cancer Pain
Fear of addiction is unwarranted
Numerous drug options for pain management
Nonpharmacologic interventions, including
relaxation therapy and imagery, can be used
effectively
Copyright © 2020 by Elsevier, Inc. All rights reserved. 128
Coping With Cancer and Treatment
(1 of 6)
Nursing assessment and support are key
➢ Pervasive anxiety and fear
• Fears of dependency
• Loss of control
• Family relationship stress
• Financial burden
• Fear of death
Copyright © 2020 by Elsevier, Inc. All rights reserved. 129
Coping With Cancer and Treatment
(2 of 6)
Many factors influence coping
➢ Demographics
➢ Prior coping skills and strategies
➢ Social support
➢ Religious and spiritual beliefs
Copyright © 2020 by Elsevier, Inc. All rights reserved. 130
Coping With Cancer and Treatment
(3 of 6)
Be available, especially during difficult times
Exhibit caring
Actively listen
Provide symptom relief
Provide accurate information
Copyright © 2020 by Elsevier, Inc. All rights reserved. 131
Coping With Cancer and Treatment
(4 of 6)
Build trust
Use touch
Assist setting realistic goals
Support usual lifestyle patterns
Maintain hope
Reassure of ongoing support
Copyright © 2020 by Elsevier, Inc. All rights reserved. 132
Coping With Cancer and Treatment
(5 of 6)
Offer support from survivors
Provide phone contact between visits
Assist with planning for
➢ Transportation
➢ Nutrition
Copyright © 2020 by Elsevier, Inc. All rights reserved. 133
Coping With Cancer and Treatment
(6 of 6)
Care for the caregiver and other family members
➢ Education
➢ Support
➢ Psychosocial intervention
➢ Resource information
Copyright © 2020 by Elsevier, Inc. All rights reserved. 134
Cancer
Gerontologic Considerations
Clinical manifestations may be mistaken for age-
related changes
More vulnerable to complications of cancer and
cancer therapy
Functional status should be considered when a
treatment plan is selected
Copyright © 2020 by Elsevier, Inc. All rights reserved. 135
Cancer Survivorship (1 of 2)
Cancer survivors continue to increase
➢ Aging and growth of the population
➢ Improvement in early detection and treatment
➢ Greater than 14.5 million in the United States
Copyright © 2020 by Elsevier, Inc. All rights reserved. 136
Cancer Survivorship (2 of 2)
Be aware of late and long-term effects of cancer
➢ Secondary cancer
➢ Cognitive changes
➢ Cardiovascular/sexual dysfunction
➢ Psychosocial effects
Copyright © 2020 by Elsevier, Inc. All rights reserved. 137
Culturally Competent Care: Cancer
Underserved populations are at risk for late-stage
disease at time of diagnosis
You need to know how to
➢ Assess for cultural differences
➢ Identify barriers to care
➢ Adapt care to meet specific cultural needs
Copyright © 2020 by Elsevier, Inc. All rights reserved. 138